C3 and systemic lupus erythematosus: However consistent with these previous studies, we found that absolute levels of sVCAM-1 were less useful as a diagnostic tool for identifying SLE patients with active disease than other conventional markers such as dsDNA antibody titre and C3 levels [8], presumably due to intrinsic variability in sVCAM-1 levels between individuals.